Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in Early Axial Spondyloarthritis (GO-GUT)
NCT03270501Phase 3Completed
- Sponsor
- Ghent University
- Start
- Nov 2017
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in axial spondyloarthritis (axSpA), sponsored by Ghent University. Started Nov 2017; status: completed.
02
Drugs
golimumab
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT03270501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270501.